Matthew T. David - 18 Feb 2022 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role
Interim CEO and CFO
Signature
/s/ Matthew T. David
Issuer symbol
CRMD
Transactions as of
18 Feb 2022
Transactions value $
$100,000
Form type
4
Filing time
23 Feb 2022, 15:09:20
Previous filing
07 Dec 2021
Next filing
18 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CRMD Common Stock 3.15K 18 Feb 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRMD Stock Option (Right to Buy Common Stock) Award $100K 100K 18 Feb 2022 Common Stock 100K $4.03 Direct F4
holding CRMD Stock Option (Right to Buy Common Stock) 125K 18 Feb 2022 Common Stock 125K $5.56 Direct F1
holding CRMD Stock Option (Right to Buy Common Stock) 80K 18 Feb 2022 Common Stock 80K $8.32 Direct F2
holding CRMD Stock Option (Right to Buy Common Stock) 125K 18 Feb 2022 Common Stock 125K $5.63 Direct F3
holding CRMD Stock Option (Right to Buy Common Stock) 125K 18 Feb 2022 Common Stock 125K $4.08 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Matthew T. David is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 These options were granted on 11/1/2021. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
F2 These options were granted on 1/11/2021. These options vest, subject to continued employment, as follows: 50% of the options vest over time, with 25% vested on the grant date and 25% vesting in equal thirds on the first, second and third anniversaries of the grant date; and 50% of the options vest upon the achievement of certain milestones.
F3 These options were granted on 05/11/2020. 83,000 of these options vest annually over four years in four equal installments beginning 05/11/2021, subject to continued employment, and 42,000 of these options vest based on achievement of certain performance milestones, subject to continued employment through the applicable vesting date.
F4 These options were granted on 2/18/2022. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.